Heterogeneity of lower airway inflammation in children with severe-persistent asthma. (Q53231621)

12 May 2018

title

Heterogeneity of lower airway inflammation in children with severe-persistent asthma. (English)

1 reference

12 May 2018

0 references

Caitlin E O'Brien

1

1 reference

12 May 2018

Kalliope Tsirilakis

2

1 reference

12 May 2018

Maria Teresa Santiago

3

1 reference

12 May 2018

David L Goldman

4

1 reference

12 May 2018

Alfin G Vicencio

5

1 reference

12 May 2018

publication date

4 March 2015

1 reference

12 May 2018

published in

Pediatric Pulmonology

1 reference

12 May 2018

volume

50

1 reference

12 May 2018

issue

12

1 reference

12 May 2018

page(s)

1200-1204

1 reference

12 May 2018

Asthma in infants and children

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Economic burden of impairment in children with severe or difficult-to-treat asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Severe asthma: an expanding and mounting clinical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Evidence for different subgroups of difficult asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Severe Asthma in Children: Insights from the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Total serum immunoglobulin e in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Relationships between exhaled nitric oxide and atopy profiles in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Neutrophil histamine contributes to inflammation in mycoplasma pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Severe asthma with fungal sensitization in a child: response to itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

CHIT1 mutations: genetic risk factor for severe asthma with fungal sensitization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

17q21 locus and ORMDL3: an increased risk for childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23165

21 January 2018

Identifiers

DOI

10.1002/PPUL.23165

1 reference

12 May 2018

1 reference

12 May 2018